Global Breast Implants Market 2017-2023: Silicone Breast Implants Dominated the Market with a Revenue of $1 Billion in 2016

Dublin, July 24, 2017 -- The "Global Breast Implants Market - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023" report has been added to Research and Markets' offering.

The global breast implants market is expected to witness a CAGR of 5.89% during the forecast period 2017-2023.

Breast implants are artificial prosthesis used for enhancement of breast muscles for a cosmetic reason. Breast augmentation or breast reconstruction refers to the aesthetic treatment of the breast to look more youthful and appealing. There are a wide range of breast implants used in performing aesthetic procedures including those used to treat deformities, injuries, or damages.

Breast reconstruction requires tissue expanders, which help in the expansion of breast muscles and skin, followed by the permanent insertion of a breast implant after the removal of the tissue expander. These procedures improve symmetry after mastectomy and have an aesthetic appearance. The US is the major revenue contributor to this market. However, the lack of reimbursement issues may restrict the market growth. The vendors in this market are striving to address the issues by conducting evidence-based studies regarding the efficacy of breast augmentation or reconstruction.

Factors, such as increase in beauty consciousness, growing awareness about reconstructive breast surgeries, favorable demographics across the globe, increasing aging population, are expected to drive the market growth during the forecast period. The market is witnessing emerging trends, such as an increase in the demand of composite breast implant treatments, a rise in medical tourism, and an increase in the disposable income, which will drive the market at a significant pace during the forecast period.

Silicone and saline breast implants are the most popular among breast augmentation and reconstruction procedures and the most common surgical aesthetic procedures among end-users. Silicone breast implants dominated the market with a revenue of $1 billion in 2016 and is expected to grow at a CAGR of 6% during the forecast period. The saline breast implants segment is growing at a slow rate and is far behind the silicone breast implants segment in terms of market growth. This is due to their low adoption rate and few other complications. In 2016, there were about 64,674 saline surgical breast implants, and these implants are more prone to rippling as they have less firmness.

The major products in the market include:

- Natrelle INSPIRA
- Natrelle Classic
- Natrelle 410
- Natrelle 133 Tissue Expanders
- MemoryShape Breast Implants
- MemoryGel Breast Implants
- Saline Breast Implants
- SPECTRUM Adjustable Saline Breast Implant
- MENTOR ARTOURA Breast Tissue Expanders
- MENTOR Volume Sizing System
- FlexHD Acellular Hydrated Dermis
- CoGel
- IMPLEO
- IMPLEO Smooth
- GFX gel-filled breast implants
- RGI silicone gel-filled breast implants
- HSC
- HSC +
- ALLOX2

Key Players:

The market is fragmented with many players but dominated by the top 5 players. Allergan, Mentor Worldwide, GC Aesthetics, and Sientra hold more than 85% of the market share in the total global breast implants market.

Competitive Analysis:

The global breast implants market is fragmented and has immense growth opportunities for the vendors, especially in the developed regions. The presence of large, small, and local vendors in the market creates high competition. The market is dominated by Allergan, Mentor Worldwide, GC Aesthetics, and Sientra. These vendors are consolidating their position in the market by acquiring smaller companies, expanding their business operations by leveraging their product portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&A. They form strategic alliances for marketing and manufacturing of breast implants.

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Characteristics
4.1 Evolution
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rise in the focus on physical appearance among women
4.2.1.2 Rising geriatric population
4.2.1.3 Favorable demographics across the globe
4.2.1.4 Increase disposable income
4.2.1.5 Growing awareness about reconstructive breast surgeries
4.2.2 Opportunities
4.2.2.1 Technological advancements
4.2.2.2 Upsurge in medical tourism
4.2.2.3 Increase in the demand for composite breast implant treatments
4.2.2.4 Increase in healthcare spending
4.2.3 Restraints
4.2.3.1 Complications and risk associated with breast implants
4.2.3.2 High cost of breast implants
4.2.3.3 Threat of counterfeit products in the market
4.2.3.4 Lack of reimbursement
4.3 DRO - Impact Analysis
4.4 Key Stakeholders

5 Types: Market Size and Analysis
5.1 Overview
5.2 Silicone breast implants
5.3 Saline breast implants

6 End-Users: Market Size and Analysis
6.1 Overview
6.2 Hospitals
6.3 Aesthetic/Surgical Centers
6.4 Physician's Office

7 Regions: Market Size and Analysis

8 Competitive Landscape
8.1 Overview

9 Vendor Profiles
9.1 Allergan plc
9.2 Mentor Worldwide LLC. (a Subsidiary of Johnson & Johnson)
9.3 GC Aesthetics plc
9.4 Sientra, Inc.

10 Companies to Watch For
10.1 Groupe Sebbin SAS
10.2 POLYTECH Health & Aesthetics GmbH
10.3 Establishment Labs S.A.
10.4 G&G Biotechnology Ltd.
10.5 Laboratories Arion.

For more information about this report visit https://www.researchandmarkets.com/research/rlmf2n/global_breast

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Surgical Procedures